ATE272393T1 - Rekonstruktion gereinigter membranproteine in vorgefertigten liposomen - Google Patents

Rekonstruktion gereinigter membranproteine in vorgefertigten liposomen

Info

Publication number
ATE272393T1
ATE272393T1 AT00980600T AT00980600T ATE272393T1 AT E272393 T1 ATE272393 T1 AT E272393T1 AT 00980600 T AT00980600 T AT 00980600T AT 00980600 T AT00980600 T AT 00980600T AT E272393 T1 ATE272393 T1 AT E272393T1
Authority
AT
Austria
Prior art keywords
liposomes
solution
providing
mixture
membrane proteins
Prior art date
Application number
AT00980600T
Other languages
German (de)
English (en)
Inventor
Pratap Singh
Original Assignee
Dade Behring Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Behring Inc filed Critical Dade Behring Inc
Application granted granted Critical
Publication of ATE272393T1 publication Critical patent/ATE272393T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
AT00980600T 1999-12-10 2000-11-20 Rekonstruktion gereinigter membranproteine in vorgefertigten liposomen ATE272393T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/459,137 US6248353B1 (en) 1999-12-10 1999-12-10 Reconstitution of purified membrane proteins into preformed liposomes
PCT/US2000/031927 WO2001041740A2 (en) 1999-12-10 2000-11-20 Reconstitution of purified membrane proteins into preformed liposomes

Publications (1)

Publication Number Publication Date
ATE272393T1 true ATE272393T1 (de) 2004-08-15

Family

ID=23823557

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00980600T ATE272393T1 (de) 1999-12-10 2000-11-20 Rekonstruktion gereinigter membranproteine in vorgefertigten liposomen

Country Status (7)

Country Link
US (2) US6248353B1 (enExample)
EP (1) EP1239833B1 (enExample)
JP (1) JP4612261B2 (enExample)
AT (1) ATE272393T1 (enExample)
DE (1) DE60012785T2 (enExample)
ES (1) ES2225271T3 (enExample)
WO (1) WO2001041740A2 (enExample)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020048596A1 (en) * 1994-12-30 2002-04-25 Gregor Cevc Preparation for the transport of an active substance across barriers
PT1031346E (pt) 1999-01-27 2002-09-30 Idea Ag Vacinacao nao invasiva atraves da pele
EP1031347B1 (en) 1999-01-27 2002-04-17 Idea Ag Transnasal transport/immunisation with highly adaptable carriers
WO2001001962A1 (en) * 1999-07-05 2001-01-11 Idea Ag. A method for the improvement of transport across adaptable semi-permeable barriers
US6248353B1 (en) * 1999-12-10 2001-06-19 Dade Behring Inc. Reconstitution of purified membrane proteins into preformed liposomes
US7592008B2 (en) * 2000-11-20 2009-09-22 The Board Of Trustees Of The University Of Illinois, A Body Corporate And Politic Of The State Of Illinois Membrane scaffold proteins
CA2429473C (en) * 2000-11-20 2011-02-15 The Board Of Trustees Of The University Of Illinois Membrane scaffold proteins
US7622437B2 (en) * 2000-11-20 2009-11-24 The Board Of Trustees Of The University Of Illinois Tissue factor compositions and methods
US7083958B2 (en) * 2000-11-20 2006-08-01 The Board Of Trustees Of The University Of Illinois Membrane scaffold proteins
US6596543B2 (en) * 2001-03-22 2003-07-22 Dade Behring Inc. Use of liposomes of defined composition and size for the preparation of prothrombin time reagents
US7015193B2 (en) * 2001-04-20 2006-03-21 University Of Vermont Compositions and methods to control bleeding
CA2477982A1 (en) * 2002-03-05 2003-09-18 Transave, Inc. Methods for entrapment of bioactive agent in a liposome or lipid complex
US7473432B2 (en) * 2002-10-11 2009-01-06 Idea Ag NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
US20050032113A1 (en) * 2003-07-17 2005-02-10 Mitsubishi Pharma Corporation Membrane protein library for proteome analysis and method for preparing same
AU2005326758B2 (en) 2004-06-23 2011-07-14 Board Of Regents Of The University Of Texas System Methods and compositions for the detection of biological molecules using a two particle complex
US7148067B2 (en) * 2004-08-31 2006-12-12 The Board Of Trustees Of The University Of Illinois Thromboplastin reagents
KR20070086045A (ko) * 2004-11-12 2007-08-27 이데아 아게 피부 상태 치료에서의 확대된 표면 집합체
CN101151533A (zh) * 2005-02-16 2008-03-26 伊利诺斯大学理事会 基于金属螯合脂质的促凝血剂
AT501650A1 (de) * 2005-02-22 2006-10-15 Technoclone Ges M B H Verfahren zur bestimmung der gerinnungsaktivierung sowie gerät zur durchführung des verfahrens
US7682808B2 (en) * 2005-03-04 2010-03-23 The Board Of Trustees Of The University Of Illinois Coagulation and fibrinolytic cascades modulator
US20070117179A1 (en) * 2005-09-27 2007-05-24 Invitrogen Corporation In vitro protein synthesis systems for membrane proteins that include adolipoproteins and phospholipid-adolipoprotein particles
JP2007106679A (ja) * 2005-10-11 2007-04-26 Shino Test Corp 血液凝固反応促進剤
EP1939218A1 (en) * 2006-12-29 2008-07-02 Thrombotargets Europe, S.L. Microvesicles derived from recombinant yeast having haemostatic activities and uses thereof
WO2008106660A2 (en) * 2007-03-01 2008-09-04 Invitrogen Corporation Isolated phospholipid-protein particles
WO2008109712A2 (en) 2007-03-05 2008-09-12 Washington University Nanoparticle delivery systems for membrane-integrating peptides
EP2197497B1 (en) 2007-09-27 2016-06-01 ImmunoVaccine Technologies Inc. Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo
EP2062661A1 (en) * 2007-09-28 2009-05-27 Proviron Holding Organic de-icer removal
US20100209452A1 (en) * 2007-10-03 2010-08-19 Immunovaccine Technologies, Inc Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
US8821861B2 (en) * 2007-10-05 2014-09-02 The Board Of Trustees Of The University Of Illinois Fibrin sealant
US20100297257A1 (en) * 2007-11-09 2010-11-25 National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs) Anticoagulant antagonist and hemophillia procoagulant
US20090220588A1 (en) * 2008-02-21 2009-09-03 Massachusetts Institute Of Technology Simultaneous Delivery of Receptors and/or Co-Receptors for Growth Factor Stability and Activity
JP5715051B2 (ja) 2008-06-05 2015-05-07 イムノバクシーン・テクノロジーズ・インコーポレイテッドＩｍｍｕｎｏｖａｃｃｉｎｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． リポソーム、抗原、ポリヌクレオチド及び疎水性物質の連続相を含む担体を含む組成物
US8956600B2 (en) 2009-08-10 2015-02-17 Taiwan Liposome Co. Ltd. Ophthalmic drug delivery system containing phospholipid and cholesterol
US12419839B2 (en) 2009-10-09 2025-09-23 Signablok, Inc. Methods and compositions for targeted delivery of protein fragments
US10525152B2 (en) 2009-10-09 2020-01-07 Signablok, Inc. Methods and compositions for targeted imaging
US10894098B2 (en) 2012-04-09 2021-01-19 Signablok, Inc. Methods and compositions for targeted imaging
KR101458315B1 (ko) 2013-07-19 2014-11-04 전북대학교산학협력단 표면 개질된 리포좀 및 그 제조방법
JP6652873B2 (ja) * 2016-03-30 2020-02-26 シスメックス株式会社 プロトロンビン時間測定用試薬、その製造方法およびプロトロンビン時間の測定方法
JP6626761B2 (ja) * 2016-03-30 2019-12-25 シスメックス株式会社 プロトロンビン時間測定用試薬およびその製造方法
US12246057B2 (en) 2018-04-13 2025-03-11 Board Of Regents, The University Of Texas System Transmembrane stem cell factor (tm-SCF) lipid nanocarriers and methods of use thereof
JP7376478B2 (ja) * 2018-07-06 2023-11-08 株式会社Ｌｓｉメディエンス リポソームを含有する液状血液凝固能測定試薬
JP7153519B2 (ja) * 2018-09-28 2022-10-14 シスメックス株式会社 凝固時間測定用試薬及びその製造方法、試薬キット及び凝固時間の測定方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL238873A (enExample) 1958-05-16
JPS56129859A (en) * 1980-03-14 1981-10-12 Sekisui Chem Co Ltd Plastic container for blood inspection
US4873089A (en) * 1985-07-12 1989-10-10 Cornell Research Foundation Inc., Cornell University Proteoliposomes as drug carriers
IL79114A (en) * 1985-08-07 1990-09-17 Allergan Pharma Method and composition for making liposomes
JPH0650999B2 (ja) 1988-09-12 1994-07-06 日本商事株式会社 血液凝固因子安定化法
US5472850A (en) 1991-04-10 1995-12-05 Oklahoma Medical Research Foundation Quantitative clotting assay for activated factor VII
DE59109269D1 (de) 1990-06-28 2005-12-15 Hoechst Ag Fusionsproteine mit Immunglobulinanteilen, ihre Herstellung und Verwendung
US5314695A (en) 1990-11-13 1994-05-24 Corvas International, Inc. Tissue factor based prothrombin time reagent
US5248590A (en) 1991-07-22 1993-09-28 Becton, Dickinson And Company Surface modified liposomes
DE69224622T2 (de) * 1991-10-04 1998-11-05 Dade Behring, Inc., Deerfield, Ill. Herstellung von prothrombinzeit-reagenzien aus rekombinantem menschlichem gewebefaktor und sythetischen phospholipiden
AU674139B2 (en) 1992-04-13 1996-12-12 Ortho Diagnostic Systems Inc. Synthetic phospholipid reagent
US5358853A (en) 1992-08-03 1994-10-25 Akzo Av Liquid thromboplastin reagent
DE4243729A1 (de) 1992-12-23 1994-06-30 Behringwerke Ag Verfahren zur Reaktivierung von gereinigten Membranproteinen
JP3591837B2 (ja) 1994-02-17 2004-11-24 ニューヨーク・ブラッド・センター・インコーポレイテッド フィブリン膠およびリポソームを含有する生物学的生体接着剤組成物、その製造方法および使用
DE4416166C2 (de) 1994-05-06 1997-11-20 Immuno Ag Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen
US6100072A (en) * 1997-04-23 2000-08-08 Instrumentation Laboratory S.P.A. Recombinant rabbit tissue factor based prothrombin time reagent
JP4039722B2 (ja) * 1997-12-01 2008-01-30 シスメックス株式会社 複合因子測定試薬
US6248353B1 (en) * 1999-12-10 2001-06-19 Dade Behring Inc. Reconstitution of purified membrane proteins into preformed liposomes

Also Published As

Publication number Publication date
US20020012699A1 (en) 2002-01-31
US6248353B1 (en) 2001-06-19
ES2225271T3 (es) 2005-03-16
DE60012785D1 (de) 2004-09-09
JP2003516525A (ja) 2003-05-13
EP1239833A2 (en) 2002-09-18
WO2001041740A3 (en) 2002-01-17
WO2001041740A2 (en) 2001-06-14
DE60012785T2 (de) 2005-08-11
JP4612261B2 (ja) 2011-01-12
US6706861B2 (en) 2004-03-16
EP1239833B1 (en) 2004-08-04

Similar Documents

Publication Publication Date Title
ATE272393T1 (de) Rekonstruktion gereinigter membranproteine in vorgefertigten liposomen
Kluft Studies on the fibrinolytic system in human plasma: quantitative determination of plasminogen activators and proactivators
CN103408655B (zh) 重组或转基因因子vii合成物，每个因子vii分子有两个带有定义了聚糖单元的n－糖基化位点
EA199900715A1 (ru) Липидные комплексы и липосомы совершенно нерастворимых комплексов платины
EA200100856A1 (ru) Способ инкапсулирования биологически активных комплексов в липосомы
ATE355826T1 (de) Verfahren zur verkapselung von nukleinsäuren in lipiddoppelschichten
RU2012148903A (ru) Обогащенные фосфолипидами везикулы, несущие тканевой фактор, обладающие гемостатической активностью, и их применения
NO2017027I2 (no) efmoroctocog alfa eller et biotilsvarende legemiddel ihht Artikkel 10(4) av Directive 2001/83/EC, som beskyttet av basispatentet.
ATE511833T1 (de) Nanopartikel aus protein mit gekoppeltem apolipoprotein e zur überwindung der blut-hirn- schranke und verfahren zu ihrer herstellung
DE69624485D1 (de) Verfahren zur herstellung hydro-monobenzoporhyrin -photosensibilisatoren enthaltender liposomen
ES2119250T3 (es) Composiciones y metodos para estimular el crecimiento y diferenciacion de megacariocitos.
NO931708D0 (no) Protrombin-tidsreagens basert paa vevsfaktor
BG104149A (bg) Белтъци, свързващи интерлевкин-18, тяхното получаване и приложение
ES2115679T3 (es) Preparacion de reactivos de tiempo de protrombina a partir de factor de tejido humano recombinante y de fosfolipidos sinteticos y naturales purificados.
JPH01503515A (ja) 脈管抗凝固性タンパク質、それらをコードするｄｎａ、それらの製造方法及びそれらの使用
CN103397011A (zh) 大部分为二天线、二唾液酸和非岩藻糖基化聚糖结构的重组或转基因因子ⅶ合成物
WO2003099830A3 (en) Cardiolipin compositions, methods of preparation and use
NO995843L (no) Farmasoeytisk preparat omfattende vWF-propeptid
EA200100652A1 (ru) Соединение (варианты) и способ его образования, способ усиления клеточной абсорбции соединения с аминогруппой, способ пролонгирования удерживания в крови и ткани млекопитающего биологически активного соединения с аминогруппой и способ его доставки во внутреннюю часть клетки, фармацевтическая композиция, фармацевтический препарат
ATE202483T1 (de) Immuntolerante prothrombinkomplex-präparation
BG101038A (bg) Супресия на растежа на туморни клетки посредствомсиндекан- 1 ектоучастък
EA200401565A1 (ru) Способ получения кардиолипина или аналога кардиолипина (варианты), способ получения липосомы и композиция кардиолипина для лечения заболеваний (варианты)
KR970706832A (ko) 지질대사개선제(lipid metabolism ameliorant)
PT948319E (pt) Celulas encapsuladas produtoras de anticorpos
Chiu et al. Restricted tissue distribution of a 37-kD possible adherens junction protein.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1239833

Country of ref document: EP